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Incubation of adipocytes with rZ51-insulin plus leupeptin or monensin, but not chloroquine, resulted in the 
appearance of a novel peak of *2sI-insulin (modal density about 1.20 g/ml) on density gradient centrifuga- 
tion; the appearance of the peak depended on the presence of specific insulin receptors on the cell surface. 
The fractions comprising this peak contained vesicles, probably originating from the Golgi apparatus, and 
dit not appear to be contaminated with lysosomes, mitochondria orplasma membrane. Entrapment of insu- 
lin in these vesicles per se did not prevent the activation of glucose transport, acetyl-CoA carboxylase or 
pyruvate dehydrogenase by insulin. 
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1. INTRODUCTION 
The mechanisms of insulin processing and ac- 
Glucose transport Acetyl-CoA carboxylase 
tion in adipocytes are incompletely understood. In- 
sulin binds to a receptor on the plasma membrane, 
is subsequently internalized by receptor-mediated 
endocytosis and some at least is transported by en- 
dosomes (vesicles of Golgi origin) to the lysosomes 
and degraded [l-4]. Insulin stimulates glucose 
transport and activates some enzymes in 
adipocytes, but the nature of the signals and their 
sites of generation are unknown; some signals are 
probably generated at the plasma membrane but 
this is not certain [l-3,5]. We report on the effects 
leupeptin, a weakly basic thiolprotease inhibitor; 
monensin, a monovalent cationic ionophore and 
chloroquine, a lysomotrophic agent, on the pro- 
cessing and action of insulin in adipocytes. 
2. EXPERIMENTAL 
The preparation and characterisation of 1251- 
labelled insulin (>85% monoiodinated) and the 
measurement of its specific and non-specific bind- 
ing to adipocytes have been described [6]. 
Parametrial adipocytes, prepared from 
150-200 g female Wistar rats [6], were incubated 
at 37OC in Ml99 [Medium 199, Cibco-Biocult, 
Paisley, Scotland (pH 7.4) containing Earle’s salts, 
L-gIutamine, 25 mM Hepes, 20 mM Tricine, 1% 
albumin (bovine, essentially fatty acid-free, Sigma, 
Poole, England), 0.2 mM penicillin and 6OpM 
streptomycin] for 1 h with ‘251-insulin (2 ng/ml). 
Cells were then washed with 2 fig/ml unlabelled in- 
sulin for 5 min to remove ‘251-insulin bound 
specifically to the cell surface receptors (this pro- 
cedure did not displace non-specifically bound 
‘*‘I-insulin from the cell surface) and homogenized 
by standing in ice-cold homogenisation buffer 
(0.25 M sucrose, 10 mM Tris-HCl, 2 mM EDTA, 
pH 7.4) for 1 h. Defatted homogenates were cen- 
trifuged at 60~ rpm (255 000 x g) for 30 min and 
the pellet was resuspended in 400~1 of 
homogenization buffer. The suspension was 
placed at the bottom of a discontinuous sucrose 
gradient and centrifuged at 27 000 rpm (85 000 x g) 
for 15 h. Fractions (1 ml) were collected from the 
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gradients and analysed for radioactivity, alkaline 
phosphodiesterase I, succinate dehydrogenase, 
5 ’ -nucleotidase, acid phosphatase [7] and galac- 
tosyl transferase [8] or prepared for electron 
microscopy [7]. 
3. RESULTS AND DISCUSSION 
Incubation of adipocytes with 500 PM leupeptin 
increased significantly @ < 0.01) by 20% the 
amount of 1251-insulin retained by the cells (inter- 
nalized insulin plus that bound non-specifically to 
the cell surface, not shown). Examination of such 
cells by electron microscopy suggested the presence 
of increased numbers of enlarged vesicles follow- 
ing incubation with leupeptin (not shown) while 
fractionation of cells by discontinuous ucrose gra- 
dient centrifugation showed that the distribution 
of 1251-insulin was markedly altered: a peak of 1251- 
insulin with a modal density of about 1.15 g/ml 
was found with cells incubated in the absence or 
presence of leupeptin, but in the presence of 
leupeptin, a novel peak with a modal density of 
about 1.2 g/ml was also present (fig.1). The 
distribution of 4 marker enzymes (alkaline 
phosphodiesterase, succinate dehydrogenase, 5 ’ - 
nucleotidase and acid phosphatase) (fig. 1) was not 
affected by leupeptin, but the distribution of a 
fifth, galactosyl transferase (a marker for Golgi 
membranes) was altered in cells incubated with 
leupeptin, with a much enlarged peak of modal 
density about 1.2 g/ml. The fractions 2-4, which 
contained the peak with a modal density of 
1.2 g/ml, were essentially free of the other en- 
zymes, suggesting that these fractions are relatively 
free of lysosomal, mitochondrial and plasma mem- 
brane fractions. Incubation of adipocytes with 
monensin (50pM) also resulted in the appearance 
of a peak of 1251-insulin with a modal density of 
about 1.2 g/ml, but, in contrast, no such peak was 
seen with cells incubated with chloroquine 
(500 PM) (fig. 1). 
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Fig. 1. Discontinuous sucrose gradient centrifugation of 
adipocyte homogenates. Adipocytes were incubated in 
Ml99 at 37°C for 60 min with ‘2SI-insulin (2 ng/ml), in 
the absence or presence of leupeptin (500 PM), monensin 
(50 PM) or chloroquine (500,~M), and subsequently 
fractionated as described in the text. Marker enzyme 
activities are expressed as percentages of the total 
activity recovered from the gradient (85-95% of that 
applied). Distributions of “‘I-insulin on gradients are 
given as 10e3 x radioactivity (cpm) per fraction. Marker 
enzyme and radioactivity distributions are representative 
of a series of experiments in which each treatment was 
carried out at least twice. 
modal density of about 1.15 g/ml was again 
observed, but not the peak with a modal density of 
1.2 g/ml (not shown). 
Pre-treatment of adipocytes with trypsin Electron microscopic analysis of fractions 6-9 
(100 fig/ml) for 15 min followed by several washes (density 1.15 g/ml) from sucrose density gradients 
with Ml99 containing 100 pg/ml trypsin inhibitor of untreated and treated cells (fig.1) showed a 
(Sigma) eliminated essentially all specific (but not heterogeneous population of vesicles. Fractions 
non-specific) binding of “‘I-insulin. When such 2-4 from leupeptin- and monensin-treated cells, 
adipocytes were incubated with 1251-insulin the but not untreated cells, also contained vesicles. 
presence and absence of leupeptin (500 PM), and These results suggest hat leupeptin and monen- 
then fractionated, the peak of ‘251-insulin with a sin cause the accumulation of insulin in vesicles, 
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possibly a form of endosome as they were 
associated with the Golgi marker, galactosyl 
transferase and appeared to be essentially free of 
the lysosomal, mitochondrial and plasma mem- 
brane markers. The appearance of the peak of in- 
sulin in fractions 2-4 seems to be dependent on the 
presence of high-affinity (specific) binding sites for 
insulin on the cell surface. As this peak of insulin 
was found only in the presence of leupeptin and 
monensin, it would appear that the vesicles are 
normally transient, and/or that leupeptin and 
monensin alter their properties (e.g., making them 
more dense). Both are possible: the insulin- 
containing endosomes identified by Suzuki and 
Kono [9] using density centrifugation had a modal 
density of about 1.06 g/ml while monensin has 
been shown to inhibit the transfer of epidermal 
growth factor, and other substances into 
lysosomes, causing their accumulation in 
endosome-like vesicles [lo]. A small peak of 
radioactivity with a modal density of about 1.06 
(fractions 16-18) was found after incubation with 
chloroquine (fig. 1). The identity of the peak of in- 
sulin with a modal density of 1.15 g/ml (fractions 
6-8, fig.1) is less clear: acid phosphatase, a 
lysosomal marker, also peaked here but the frac- 
tions were contaminated with other marker 
enzymes. 
Monensin, but not leupeptin, markedly de- 
creased the basal and insulin-stimulated uptake of 
2-deoxyglucose into adipocytes @ < 0.05) (fig.2). 
Similar results were obtained using an insulin con- 
centration of 20 ng/ml (not shown). In contrast, 
leupeptin, but not monensin inhibited (p < 0.05) 
insulin-induced activation of acetyl CoA carbox- 
ylase (ACC) (fig.2), while neither impaired the ac- 
tivation of pyruvate dehydrogenase (PDH) by in- 
sulin. Leupeptin did not prevent stimulation of 
glucose oxidation or activation of glycogen syn- 
thetase by insulin in adipocytes [l 11. Insulin pro- 
motes the translocation of Golgi vesicles carrying 
the glucose translocase to the plasma membrane 
[121, and monensin has been shown in other 
systems to disrupt the intracellular transport of 
Golgi vesicles [3]. So, as the apparent entrapment 
of insulin in some form of endosome by leupeptin 
did not prevent insulin stimulation of glucose 
transport or activation of PDH, while monensin 
did not prevent activation of ACC, the results pro- 
vide further evidence that the insulin-induced 
Fig.2. Effects of leupeptin and monensin on insulin 
stimulation of glucose transport and activation of acetyl 
CoA carboxylase (ACC) and pyruvate dehydrogenase 
(PDH). Adipocytes were incubated in either Krebs’ 
Ringer phosphate buffer (pH 7.4) containing 1% 
albumin (glucose transport) or Ml99 (ACC and PDH) at 
37°C for 60 min in the absence (C) or presence of 
SOO~M leupeptin (L) or 50 PM monensin (M), with 
I or without =) insulin (2 g/ml). Glucose 
transport was measured using 3 nM 2-deoxy-D- 
[I-‘HIglucose [13]. For enzyme assay, adipocytes were 
centrifuged through 100 1 of dinonylphthalate oil and 
frozen in liquid nitrogen. The initial activity of ACC 
(i.e., in the absence of citrate and without preincubation 
with citrate) was measured as described previously [14] 
except that the incubation time was decreased to 3 min, 
and is expressed as a fraction of the activity of lactate 
dehydrogenase (LDH) x 10m3 of the preparation. PDH 
was assayed spectrophotometrically [ 151. Results are the 
means and SE from 3,4 and 1 separate xperiments each 
using pooled adipocytes from 4 or 5 rats for glucose 
transport, ACC and PDH, respectively. 
signals stimulating these processes are produced at 
an early stage of the interaction of insulin with the 
adipocyte, prior to the formation of the putative 
endosome. Furthermore, as monensin disrupts the 
movement of vesicles within the cell [12], transmis- 
sion of the signal from the plasma membrane to 
453 
Volume 182, number 2 FEBS LETTERS March 1985 
the mitochondria to activate PDH does not appear 
to involve transport in such intracellular vesicles. 
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